Molecular Determinants for Antibody Binding on Group 1 House Dust Mite Allergens

House dust mites produce potent allergens, Der p 1 and Der f 1, that cause allergic sensitization and asthma. Der p 1 and Der f 1 are cysteine proteases that elicit IgE responses in 80% of mite-allergic subjects and have proinflammatory properties. Their antigenic structure is unknown. Here, we pres...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 287; no. 10; pp. 7388 - 7398
Main Authors Chruszcz, Maksymilian, Pomés, Anna, Glesner, Jill, Vailes, Lisa D., Osinski, Tomasz, Porebski, Przemyslaw J., Majorek, Karolina A., Heymann, Peter W., Platts-Mills, Thomas A.E., Minor, Wladek, Chapman, Martin D.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 02.03.2012
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:House dust mites produce potent allergens, Der p 1 and Der f 1, that cause allergic sensitization and asthma. Der p 1 and Der f 1 are cysteine proteases that elicit IgE responses in 80% of mite-allergic subjects and have proinflammatory properties. Their antigenic structure is unknown. Here, we present crystal structures of natural Der p 1 and Der f 1 in complex with a monoclonal antibody, 4C1, which binds to a unique cross-reactive epitope on both allergens associated with IgE recognition. The 4C1 epitope is formed by almost identical amino acid sequences and contact residues. Mutations of the contact residues abrogate mAb 4C1 binding and reduce IgE antibody binding. These surface-exposed residues are molecular targets that can be exploited for development of recombinant allergen vaccines. A unique, cross-reacting monoclonal antibody binds both Der f 1 and Der p 1. A common epitope present on both Der f 1 and Der p 1 was identified and mutated. Mutagenesis and antibody binding analysis allowed identification of IgE antibody binding sites. The obtained data will lead to the production of hypoallergens with low IgE antibody binding capacity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
National Institutes of Health (NIH)
Both authors contributed equally to this work and should be considered co-first authors.
ISSN:0021-9258
1083-351X
1083-351X
DOI:10.1074/jbc.M111.311159